A gland transplant that could end a lifetime of calcium shots?

NCT ID NCT05114980

First seen Aug 21, 2026 · Last updated Aug 21, 2026

Summary

This trial tests whether transplanting parathyroid glands from a donor can help people with severe hypoparathyroidism—a condition where the body can't regulate calcium, often after neck surgery. Participants are adults aged 18-80 who have had the condition for at least a year and still need IV calcium despite medical treatment. The study will see if the transplanted glands produce parathyroid hormone and reduce the need for calcium supplements, while also monitoring for side effects from immunosuppression.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Parathyroid allotransplantation (transplant of donor parathyroid glands)
What this could lead to
If successful, this could offer a lasting treatment—or even a cure—for people with severe hypoparathyroidism who don't respond to standard therapy.
What could go wrong
This is an early, experimental procedure performed at only a few centers worldwide. Risks include transplant rejection, complications from immunosuppression, and the possibility that the transplanted glands may not function long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPOPARATHYROIDISM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Alabama at Birmingham

    Birmingham, Alabama, 35294, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.